Avidity Partners Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.6M | Sell |
|
|||||
|
2025
Q1 | $11.7M | Sell |
|
|||||
|
2024
Q4 | $14.8M | Sell |
|
|||||
|
2024
Q3 | $41.8M | Sell |
|
|||||
|
2024
Q2 | $39.5M | Buy |
|
|||||
|
2024
Q1 | $43.6M | Buy |
|
|||||
|
2023
Q4 | $40.4M | Buy |
|
|||||
|
2023
Q3 | $19.4M | Sell |
|
|||||
|
2023
Q2 | $41.5M | Sell |
|
|||||
|
2023
Q1 | $85.3M | Sell |
|
|||||
|
2022
Q4 | $139M | Buy |
|
|||||
|
2022
Q3 | $85M | Buy |
|
|||||
|
2022
Q2 | $88.3M | Buy |
|
|||||
|
2022
Q1 | $63.1M | Buy |
|
|||||
|
2021
Q4 | $58.9M | Buy |
|
|||||
|
2021
Q3 | $41M | Buy |
|